<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04236531</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A02499-48</org_study_id>
    <nct_id>NCT04236531</nct_id>
  </id_info>
  <brief_title>Source-monitoring &amp; Psychosis</brief_title>
  <acronym>SOURIPSY</acronym>
  <official_title>Source-monitoring Processes and Risk for Psychosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital le Vinatier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital le Vinatier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Source-monitoring is a cognitive process that refers to the ability to remember the source of
      an information. Some studies have showed source-monitoring deficits in patients with
      schizophrenia as well as in individuals at ultra-high risk for psychosis (UHR) and in
      first-episode psychosis patients (FEP). Source-monitoring deficits have thus been proposed as
      a potential early risk factor for psychosis. However, further studies are needed to better
      characterize this deficit.

      The aim of this project is to investigate source-monitoring performances in UHR, FEP patients
      and healthy controls (HC) and to characterize these deficits in terms of brain anatomy, basic
      auditory processes and social functioning.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ninety participants will be included in the study: 30 UHR, 30 FEP and 30 healthy controls.
      All the participants will complete a standardized source-monitoring task, an MRI acquisition
      (3D-T1 anatomical scan), a tone-matching task as well as a socio-demographic and clinical
      evaluation including an assessment of the social functioning.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2020</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">October 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Three groups of participants will be recruited: individuals at ultra-high risk for psychosis, first-episode psychosis patients and healthy controls.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Source-monitoring performances</measure>
    <time_frame>one day</time_frame>
    <description>Scores obtained at a source-monitoring task (Brunelin et al., 2006)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Confidence in source-monitoring judgements</measure>
    <time_frame>one day</time_frame>
    <description>Confidence in source-monitoring judgements will be measured using a visual analogue scale (0-100)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grey matter volume</measure>
    <time_frame>one day</time_frame>
    <description>Grey matter volume will be assessed with a structural MRI scan (3D-T1) followed by morphometry analyses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain gyrification</measure>
    <time_frame>one day</time_frame>
    <description>Brain gyrification will be assessed with a structural MRI scan (3D-T1) followed by gyrification analyses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Basic auditory performances</measure>
    <time_frame>one day</time_frame>
    <description>scores at the Tone Matching Task (Strous et al., 1995)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Working memory performances</measure>
    <time_frame>one day</time_frame>
    <description>scores at a working memory task (Barrouillet et al., 2004)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social functioning</measure>
    <time_frame>one day</time_frame>
    <description>score at the &quot;personal and social performance scale&quot; (0-100)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Psychosis</condition>
  <arm_group>
    <arm_group_label>individuals at ultra-high risk for psychosis (UHR)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 individuals meeting the UHR criteria according to the &quot;Comprehensive Assessment of at-risk mental state&quot; (CAARMS) will be recruited and will complete cognitive task and MRI scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with first episode psychosis (FEP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 patients with first episode psychosis (FEP) will be recruited and will complete cognitive task and MRI scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy controls</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>30 healthy individuals will be recruited and will complete cognitive task and MRI scan</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cognitive tests and neuroimaging</intervention_name>
    <description>comparison of cognitive performances and brain anatomy</description>
    <arm_group_label>healthy controls</arm_group_label>
    <arm_group_label>individuals at ultra-high risk for psychosis (UHR)</arm_group_label>
    <arm_group_label>patients with first episode psychosis (FEP)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and Women aged between 18 and 30

          -  Having given their written informed consent

          -  French speakers and readers

          -  Absence of hearing impairments (or tinnitus) that could prevent the successful
             completion of tasks involving listening to sounds or words

          -  Absence of visual impairments that could prevent the successful completion of tasks
             involving reading on the screen

          -  For the healthy control group, no history of previous diagnosed psychiatric disorders
             (according to the criteria of the Diagnostic and Statistical Manual of Mental
             Disorders - DSM5), absence of relatives diagnosed with spectrum disorder schizophrenia
             and bipolar disorder (DSM5), absence of psychotic prodromes measured by a score of
             less than 6 in the &quot;prodromal questionnaire&quot; - PQ-16 (Ising et al., 2012), absence of
             drug treatments (except oral contraception).

          -  For the UHR group, meeting the UHR criteria according to the &quot;Comprehensive Assessment
             of at-risk mental state&quot; (CAARMS).

          -  For the FEP group, presenting with daily psychotic symptoms for at least a week.

        Exclusion Criteria:

          -  Do not consent to be included in the study

          -  Contraindication to MRI scan

          -  History of neurological disease

          -  Pregnancy

          -  Being under tutorship or curatorship

          -  Having developed musical abilities (that is, regularly practicing a musical
             instrument)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lydie sartelet</last_name>
    <phone>0437915531</phone>
    <phone_ext>+33</phone_ext>
    <email>lydie.sartelet@ch-le-vinatier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier le Vinatier</name>
      <address>
        <city>Bron</city>
        <zip>69678</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Marine Mondino</last_name>
      <phone>0437915565</phone>
      <phone_ext>+33</phone_ext>
      <email>marine.mondino@ch-le-vinatier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Jérôme Brunelin</last_name>
      <phone>0437915297</phone>
      <phone_ext>+33</phone_ext>
      <email>jerome.brunelin@ch-le-vinatier.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Marine Mondino</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hanna Chainay</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frédéric Haesebaert</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jerome Brunelin</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 6, 2020</study_first_submitted>
  <study_first_submitted_qc>January 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2020</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>source-monitoring</keyword>
  <keyword>at-risk</keyword>
  <keyword>MRI</keyword>
  <keyword>neuroimaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

